Our Management Team
Our Management Team brings together wide-ranging expertise from across the whole of cancer care and rare diseases through product development of therapies through to commercialization products. We’re focused on pushing further to deliver more life-changing treatments for people with cancer today and in the future.
Helsinn’s Senior Executive Committee Team
Riccardo Braglia
Group Vice Chairman & CEO, Board Member & US Chairman
Giorgio Calderari
Group General Manager & Chief Operating Officer & U.S. Board Member
Konrad Wilson
Group Chief Financial Officer
Andrea Meoli
Group Chief Commercial Officer
Sergio Cantoreggi
Group Chief Scientific Officer and Global Head of R&D
Matteo Missaglia
Group General Counsel and Chief Legal Officer
Helsinn's Management Team
Waldo Mossi
Local General Manager, Helsinn Advanced Synthesis SA, Switzerland
Roberta Cannella
Group Head of Manufacturing and CMC
Paul Rittman
Local CEO, Helsinn Therapeutics (U.S.), Inc., USA
Cristina Marenzi
Group Head of Human Resources
Enrico Magnani
Local General Manager, Helsinn Pharmaceuticals (Beijing) Co., Ltd., P.R.C.
Matteo Santi
Group Compliance Officer and Group Head of Compliance and Quality
Deirdre Hurley
Local General Manager, Helsinn Birex Pharmaceuticals Ltd., Ireland
Roberto Lazari
Group Head of Information and Communications Technology
Georg Büchner
Group Head of Business Development